Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Gastroenterology & Hepatology|September 28, 2022
Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel diseaseAnja Eberl, Sami Qadri, Päivi Saavalainen, et al.
Inflammatory Bowel Diseases|September 18, 2010
Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CDTaina Sipponen, Hannu Nuutinen, Ulla Turunen, et al.
Scandinavian Journal of Gastroenterology|December 17, 2019
Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseasesPauliina Molander, Helena Kemppainen, Tuire Ilus, et al.
Scandinavian Journal of Gastroenterology|March 31, 2012
Radiation exposure during nasojejunal intubation for MRI enteroclysisLauri Puustinen, Kirsti Numminen, Jouni Uusi-Simola, et al.
International Journal of Colorectal Disease|October 1, 2013
Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel diseaseKaija-Leena Kolho, Taina Sipponen, Elsa Valtonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2016
[Exemplary cases of individualization of biological therapy]Taina Sipponen, Pia Isomäki, Sanna Leinonen, et al.
Journal of Clinical Gastroenterology|December 23, 2008
Three-generation familial visceral myopathy with alpha-actin-positive inclusion bodies in intestinal smooth muscleTaina Sipponen, Riitta Karikoski, Hannu Nuutinen, et al.
Scandinavian Journal of Gastroenterology|July 3, 2015
Does oral α-galactosidase relieve irritable bowel symptoms?Markku Hillilä, Martti A Färkkilä, Taina Sipponen, et al.
Scandinavian Journal of Gastroenterology|September 4, 2018
The impact of an adaptation course on health-related quality of life and functional capacity of patients with inflammatory bowel diseaseJohanna Haapamäki, Erjastiina Heikkinen, Taina Sipponen, et al.
World Journal of Gastroenterology|December 15, 2010
Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's diseaseHanne Rintamäki, Taina Sipponen, Harri-M Salo, et al.
Pageof 7